Cargando…

‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging

[Image: see text] The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuypers, Eva, Claes, Britt S. R., Biemans, Rianne, Lieuwes, Natasja G., Glunde, Kristine, Dubois, Ludwig, Heeren, Ron M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047448/
https://www.ncbi.nlm.nih.gov/pubmed/35413180
http://dx.doi.org/10.1021/acs.analchem.1c05238
_version_ 1784695728230105088
author Cuypers, Eva
Claes, Britt S. R.
Biemans, Rianne
Lieuwes, Natasja G.
Glunde, Kristine
Dubois, Ludwig
Heeren, Ron M. A.
author_facet Cuypers, Eva
Claes, Britt S. R.
Biemans, Rianne
Lieuwes, Natasja G.
Glunde, Kristine
Dubois, Ludwig
Heeren, Ron M. A.
author_sort Cuypers, Eva
collection PubMed
description [Image: see text] The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis. Here, we applied mass spectrometry imaging (MSI) to acquire and visualize the molecular profiles at the single-cell and subcellular levels of 14 different breast cancer cell lines. We built a molecular library of genetically well-characterized cell lines. Multistep processing, including deep learning, resulted in a breast cancer subtype, the cancer’s hormone status, and a genotypic recognition model based on metabolic phenotypes with cross-validation rates of up to 97%. Moreover, we applied our single-cell-based recognition models to complex tissue samples, identifying cell subtypes in tissue context within seconds during measurement. These data demonstrate “on the spot” digital pathology at the single-cell level using MSI, and they provide a framework for fast and accurate high spatial resolution diagnostics and prognostics.
format Online
Article
Text
id pubmed-9047448
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-90474482022-04-29 ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging Cuypers, Eva Claes, Britt S. R. Biemans, Rianne Lieuwes, Natasja G. Glunde, Kristine Dubois, Ludwig Heeren, Ron M. A. Anal Chem [Image: see text] The molecular pathology of breast cancer is challenging due to the complex heterogeneity of cellular subtypes. The ability to directly identify and visualize cell subtype distribution at the single-cell level within a tissue section enables precise and rapid diagnosis and prognosis. Here, we applied mass spectrometry imaging (MSI) to acquire and visualize the molecular profiles at the single-cell and subcellular levels of 14 different breast cancer cell lines. We built a molecular library of genetically well-characterized cell lines. Multistep processing, including deep learning, resulted in a breast cancer subtype, the cancer’s hormone status, and a genotypic recognition model based on metabolic phenotypes with cross-validation rates of up to 97%. Moreover, we applied our single-cell-based recognition models to complex tissue samples, identifying cell subtypes in tissue context within seconds during measurement. These data demonstrate “on the spot” digital pathology at the single-cell level using MSI, and they provide a framework for fast and accurate high spatial resolution diagnostics and prognostics. American Chemical Society 2022-04-12 2022-04-26 /pmc/articles/PMC9047448/ /pubmed/35413180 http://dx.doi.org/10.1021/acs.analchem.1c05238 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Cuypers, Eva
Claes, Britt S. R.
Biemans, Rianne
Lieuwes, Natasja G.
Glunde, Kristine
Dubois, Ludwig
Heeren, Ron M. A.
‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
title ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
title_full ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
title_fullStr ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
title_full_unstemmed ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
title_short ‘On the Spot’ Digital Pathology of Breast Cancer Based on Single-Cell Mass Spectrometry Imaging
title_sort ‘on the spot’ digital pathology of breast cancer based on single-cell mass spectrometry imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047448/
https://www.ncbi.nlm.nih.gov/pubmed/35413180
http://dx.doi.org/10.1021/acs.analchem.1c05238
work_keys_str_mv AT cuyperseva onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging
AT claesbrittsr onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging
AT biemansrianne onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging
AT lieuwesnatasjag onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging
AT glundekristine onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging
AT duboisludwig onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging
AT heerenronma onthespotdigitalpathologyofbreastcancerbasedonsinglecellmassspectrometryimaging